Cargando…
Potential health risks of complementary alternative medicines in cancer patients
Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410154/ https://www.ncbi.nlm.nih.gov/pubmed/14735185 http://dx.doi.org/10.1038/sj.bjc.6601560 |
_version_ | 1782155939749560320 |
---|---|
author | Werneke, U Earl, J Seydel, C Horn, O Crichton, P Fannon, D |
author_facet | Werneke, U Earl, J Seydel, C Horn, O Crichton, P Fannon, D |
author_sort | Werneke, U |
collection | PubMed |
description | Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks. |
format | Text |
id | pubmed-2410154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24101542009-09-10 Potential health risks of complementary alternative medicines in cancer patients Werneke, U Earl, J Seydel, C Horn, O Crichton, P Fannon, D Br J Cancer Clinical Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks. Nature Publishing Group 2004-01-26 2004-01-20 /pmc/articles/PMC2410154/ /pubmed/14735185 http://dx.doi.org/10.1038/sj.bjc.6601560 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Werneke, U Earl, J Seydel, C Horn, O Crichton, P Fannon, D Potential health risks of complementary alternative medicines in cancer patients |
title | Potential health risks of complementary alternative medicines in cancer patients |
title_full | Potential health risks of complementary alternative medicines in cancer patients |
title_fullStr | Potential health risks of complementary alternative medicines in cancer patients |
title_full_unstemmed | Potential health risks of complementary alternative medicines in cancer patients |
title_short | Potential health risks of complementary alternative medicines in cancer patients |
title_sort | potential health risks of complementary alternative medicines in cancer patients |
topic | Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410154/ https://www.ncbi.nlm.nih.gov/pubmed/14735185 http://dx.doi.org/10.1038/sj.bjc.6601560 |
work_keys_str_mv | AT wernekeu potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients AT earlj potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients AT seydelc potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients AT horno potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients AT crichtonp potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients AT fannond potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients |